Devyser Diagnostics AB (publ) (STO: DVYSR)
Sweden
· Delayed Price · Currency is SEK 129.00
-3.50 (-2.64%)
Jan 20, 2025, 5:29 PM CET
Devyser Diagnostics AB Market Cap
Devyser Diagnostics AB has a market cap or net worth of 2.13 billion as of January 21, 2025. Its market cap has increased by 67.24% in one year.
Market Cap
2.13B
Enterprise Value
2.02B
Revenue
198.10M
Ranking
n/a
PE Ratio
n/a
Stock Price
129.00
Market Cap Chart
Since December 10, 2021, Devyser Diagnostics AB's market cap has increased from 1.35B to 2.13B, an increase of 57.56%. That is a compound annual growth rate of 15.71%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 20, 2025 | 2.13B | 8.86% |
| Dec 30, 2024 | 1.96B | 52.85% |
| Dec 29, 2023 | 1.28B | 11.06% |
| Dec 30, 2022 | 1.15B | -14.36% |
| Dec 30, 2021 | 1.35B | -0.45% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Swedish Orphan Biovitrum AB | 113.61B |
| Getinge AB | 52.49B |
| Sectra AB | 48.16B |
| Camurus AB | 33.40B |
| Medicover AB | 30.10B |
| Vitrolife AB | 28.16B |
| Bonesupport Holding AB | 24.57B |
| Elekta AB | 24.22B |